Does AGALSIDASE BETA Cause Dyspnoea? 266 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 266 reports of Dyspnoea have been filed in association with AGALSIDASE BETA (Fabrazyme). This represents 4.2% of all adverse event reports for AGALSIDASE BETA.
266
Reports of Dyspnoea with AGALSIDASE BETA
4.2%
of all AGALSIDASE BETA reports
18
Deaths
105
Hospitalizations
How Dangerous Is Dyspnoea From AGALSIDASE BETA?
Of the 266 reports, 18 (6.8%) resulted in death, 105 (39.5%) required hospitalization, and 11 (4.1%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AGALSIDASE BETA. However, 266 reports have been filed with the FAERS database.
What Other Side Effects Does AGALSIDASE BETA Cause?
Malaise (409)
Pain (395)
Pyrexia (362)
Fatigue (338)
Nausea (303)
Weight decreased (272)
Headache (269)
Chills (259)
Vomiting (244)
Pain in extremity (235)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which AGALSIDASE BETA Alternatives Have Lower Dyspnoea Risk?
AGALSIDASE BETA vs AGOMELATINE
AGALSIDASE BETA vs ALAWAY
AGALSIDASE BETA vs ALBENDAZOLE
AGALSIDASE BETA vs ALBIGLUTIDE
AGALSIDASE BETA vs ALBUMIN